Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Intern Med ; 171(14): 1270-8, 2011 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-21788542

RESUMO

BACKGROUND: The increasing prevalence of uropathogens resistant to antimicrobial agents has stimulated interest in cranberries to prevent recurrent urinary tract infections (UTIs). METHODS: In a double-blind, double-dummy noninferiority trial, 221 premenopausal women with recurrent UTIs were randomized to 12-month prophylaxis use of trimethoprim-sulfamethoxazole (TMP-SMX), 480 mg once daily, or cranberry capsules, 500 mg twice daily. Primary end points were the mean number of symptomatic UTIs over 12 months, the proportion of patients with at least 1 symptomatic UTI, the median time to first UTI, and development of antibiotic resistance in indigenous Escherichia coli. RESULTS: After 12 months, the mean number of patients with at least 1 symptomatic UTI was higher in the cranberry than in the TMP-SMX group (4.0 vs 1.8; P = .02), and the proportion of patients with at least 1 symptomatic UTI was higher in the cranberry than in the TMP-SMX group (78.2% vs 71.1%). Median time to the first symptomatic UTI was 4 months for the cranberry and 8 months for the TMP-SMX group. After 1 month, in the cranberry group, 23.7% of fecal and 28.1% of asymptomatic bacteriuria E coli isolates were TMP-SMX resistant, whereas in the TMP-SMX group, 86.3% of fecal and 90.5% of asymptomatic bacteriuria E coli isolates were TMP-SMX resistant. Similarly, we found increased resistance rates for trimethoprim, amoxicillin, and ciprofloxacin in these E coli isolates after 1 month in the TMP-SMX group. After discontinuation of TMP-SMX, resistance reached baseline levels after 3 months. Antibiotic resistance did not increase in the cranberry group. Cranberries and TMP-SMX were equally well tolerated. CONCLUSION: In premenopausal women, TMP-SMX, 480 mg once daily, is more effective than cranberry capsules, 500 mg twice daily, to prevent recurrent UTIs, at the expense of emerging antibiotic resistance. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN50717094.


Assuntos
Antibacterianos/uso terapêutico , Anti-Infecciosos Urinários/uso terapêutico , Infecções por Escherichia coli/prevenção & controle , Escherichia coli/efeitos dos fármacos , Pré-Menopausa , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Infecções Urinárias/prevenção & controle , Vaccinium macrocarpon , Adulto , Amoxicilina/farmacologia , Cápsulas , Ciprofloxacina/farmacologia , Método Duplo-Cego , Esquema de Medicação , Farmacorresistência Bacteriana , Feminino , Humanos , Pessoa de Meia-Idade , Preparações de Plantas/uso terapêutico , Prevenção Secundária , Resultado do Tratamento
2.
Int J Antimicrob Agents ; 27(3): 236-41, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16473503

RESUMO

A population-based study was conducted among women over the age of 70 years with complaints of uncomplicated urinary tract infections (UTIs). The positive predictive value of the nitrite test alone or in combination with the leukocyte esterase test ranged between 83% and 99%. The nitrofurantoin prescription rate decreased whereas fluoroquinolone and amoxicillin/clavulanic acid prescriptions increased with increasing age. The aetiology of infection was age-dependent. Escherichia coli was the most commonly isolated uropathogen, followed by Proteus mirabilis and Klebsiella pneumoniae. For these uropathogens, the lowest susceptibility percentages were found for amoxicillin, trimethoprim and co-trimoxazole. As trimethoprim susceptibility reached approximately 75%, it may be advisable not to use this as a first-choice agent in the treatment of uncomplicated UTIs in the elderly.


Assuntos
Anti-Infecciosos/uso terapêutico , Bactérias/efeitos dos fármacos , Infecções Urinárias/microbiologia , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/farmacocinética , Bactérias/isolamento & purificação , Farmacorresistência Bacteriana , Feminino , Humanos , Testes de Sensibilidade Microbiana , Vigilância da População , Infecções Urinárias/diagnóstico , Infecções Urinárias/tratamento farmacológico , Urina/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA